Circulation, Vol 86, 131-137, Copyright © 1992 by American Heart Association
FW Bar, FW Verheugt, J Col, P Materne, JP Monassier, PG Geslin, J Metzger, P Raynaud, J Foucault and C de Zwaan
BACKGROUND. The value of thrombolytic therapy in unstable angina is
unclear. METHODS AND RESULTS. To study this problem, 159 patients were
studied in a double-blind, placebo-controlled multicenter trial. Patients
without a previous myocardial infarction, with a typical history of
unstable angina, and ECG abnormalities indicative of ischemia were
included. After baseline angiography, study medication (anistreplase or
placebo) was given. Angiography was repeated after 12- 28 hours. A
significant decrease occurred in diameter stenosis between the first and
second angiogram in the anistreplase group compared with the placebo group
(11% versus 3%, p = 0.008). This difference was caused by reopening of
occluded vessels in the thrombolytic group. However, no beneficial clinical
effects of thrombolytic treatment were found. Bleeding complications were
significantly higher in patients who received thrombolytic therapy (21
versus seven patients, p = 0.001). CONCLUSIONS. Thus, angiographic but no
clinical improvement after thrombolytic treatment with anistreplase was
found in patients with unstable angina with an excess of bleeding
complications. Therefore, thrombolytic treatment cannot be recommended in
patients diagnosed as having unstable angina until proven otherwise.
ARTICLES
Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase
Academic Hospital Maastricht, The Netherlands.
This article has been cited by other articles:
![]() |
G. N. Levine, M. N. Ali, and A. I. Schafer Antithrombotic Therapy in Patients With Acute Coronary Syndromes Arch Intern Med, April 9, 2001; 161(7): 937 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yeghiazarians, J. B. Braunstein, A. Askari, and P. H. Stone Unstable Angina Pectoris N. Engl. J. Med., January 13, 2000; 342(2): 101 - 114. [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhao, P. Theroux, S. M. Snapinn, and F. L. Sax Intracoronary Thrombus and Platelet Glycoprotein IIb/IIIa Receptor Blockade With Tirofiban in Unstable Angina or Non-Q-Wave Myocardial Infarction : Angiographic Results From the PRISM-PLUS Trial (Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms) Circulation, October 12, 1999; 100(15): 1609 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Giugliano, C. A. Camargo Jr, D. M. Lloyd-Jones, J. D. Zagrodsky, J. D. Alexis, K. A. Eagle, V. Fuster, and C. J. O'Donnell Elderly Patients Receive Less Aggressive Medical and Invasive Management of Unstable Angina: Potential Impact of Practice Guidelines Arch Intern Med, May 25, 1998; 158(10): 1113 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Platelet Receptor Inhibition in Ischemic Syndr A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable Angina N. Engl. J. Med., May 21, 1998; 338(21): 1498 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Owa, H. Origasa, M. Saito, and M. Owa Predictive Validity of the Braunwald Classification of Unstable Angina for Angiographic Findings, Short-Term Prognoses, and Treatment Selection Angiology, August 1, 1997; 48(8): 663 - 671. [Abstract] [PDF] |
||||
![]() |
K.M.A. Hussain, L. Gould, T. Bharathan, M. Angirekula, S. Choubey, and Yu. Karpov Arteriographic Morphology and Intracoronary Thrombus in Patients with Unstable Angina, Non-Q Wave Myocardial Infarction and Stable Angina Pectoris Angiology, March 1, 1995; 46(3): 181 - 189. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |